Text Size
1990 studies found for:    "Merck" [Exact]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain
Condition: Postoperative Pain
Interventions: Drug: MK0966, rofecoxib;   Drug: Comparator: valdecoxib
2 Completed Lipid Efficacy and Safety in Patients With Mixed Hyperlipidemia (MK-0524B-024)(COMPLETED)
Condition: Mixed Hyperlipidemia
Interventions: Drug: Comparator: MK0524B;   Drug: Comparator: Atorvastatin
3 Terminated
Has Results 		Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: MK-0941;   Drug: Comparator: Placebo;   Biological: Lantus;   Drug: Metformin
4 Completed Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550 AM3)
Condition: Parkinson Disease
Interventions: Drug: Treatment A;   Drug: Treatment B;   Drug: Treatment C
5 Completed
Has Results 		A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension
Condition: Hypertension
Interventions: Drug: losartan potassium;   Drug: Comparator: placebo;   Drug: hydrochlorothiazide (HCTZ)
6 Terminated A Study of MK1775 in Combination With Topotecan/Cisplatin in Patients With Cervical Cancer (1775-008)
Condition: Cervical Cancer
Interventions: Drug: MK1775 + topotecan + cisplatin;   Drug: Comparator: MK1775 + topotecan + cisplatin;   Drug: Comparator: Placebo to MK1775 + topotecan + cisplatin
7 Active, not recruiting A Study to Assess Safety and Efficacy of Odanacatib (MK-0822) in Men With Osteoporosis (MK-0822-053 AM1)
Condition: Osteoporosis
Interventions: Drug: Odanacatib;   Drug: Placebo for Odanacatib
8 Active, not recruiting A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402 AM2)
Condition: Parkinson's Disease
Interventions: Drug: Preladenant;   Drug: Placebo tablet to match Preladenant
9 Completed A Study to Investigate Biomarkers After Single Doses of Anticoagulants in Healthy Young Male and Healthy Elderly Participants (MK-0000-216 AM1)
Condition: Thrombosis
Interventions: Drug: dabigatran etexilate;   Drug: rivaroxaban
10 Not yet recruiting A Multiple Dose Study of MK-5172 in Hepatitis C-Infected Participants (MK-5172-010 AM1)
Condition: Hepatitis
Intervention: Drug: MK-5172
11 Recruiting Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059 AM1)
Condition: Hepatitis C, Chronic
Interventions: Drug: PEG-IFN alfa-2b;   Drug: ribivirin
12 Enrolling by invitation Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689 AM1)
Condition: Schizophrenia
Interventions: Drug: Asenapine;   Drug: Placebo Asenapine;   Drug: Olanzapine;   Drug: Placebo Olanzapine
13 Recruiting A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy (MK-0859-021 AM1)
Condition: Hypercholesterolemia
Interventions: Drug: Anacetrapib 100 mg;   Drug: Placebo for anacetrapib 100 mg;   Drug: Anacetrapib 25 mg;   Drug: Placebo for anacetrapib 25 mg
14 Terminated
Has Results 		An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients
Condition: Lymphoma
Interventions: Drug: vorinostat;   Drug: Comparator: bexarotene
15 Completed Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis
Condition: Chemotherapy Induced Nausea and Vomiting
Intervention: Behavioral: Disease Management Assessment
16 Completed A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol
Condition: Cholesterol
Interventions: Drug: ezetimibe;   Drug: Comparator: Placebo (unspecified);   Drug: simvastatin
17 Completed MK0524 Asthma POC Study
Condition: Asthma
Interventions: Drug: Comparator: MK0524 + placebo;   Drug: Comparator: MK0524 + montelukast;   Drug: Comparator: placebo + montelukast;   Drug: Comparator: Placebo
18 Completed
Has Results 		A Study to Test the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK1006 (MK-1006-002)(COMPLETED)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: MK1006;   Drug: Placebo
19 Completed BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs
Condition: Dementia
Interventions: Drug: MK3134;   Drug: Comparator: Placebo;   Drug: Donepezil
20 Terminated
Has Results 		The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)
Conditions: Coronary Artery Bypass;   Myocardial Infarction;   Ventricular Dysfunction, Left;   Stroke;   Cardiopulmonary Bypass
Interventions: Drug: Acadesine;   Drug: Normal Saline
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years